跳至主導覽
跳至搜尋
跳過主要內容
澳門理工大學 首頁
English
中文
首頁
研究單位
研究成果
學術履歷
新聞/媒體
按專業知識、姓名或所屬機構搜尋
連絡專家
查看斯高帕斯 (Scopus) 概要
李 克峰
Associate Professor
Associate Professor
,
Faculty of Applied Sciences
電話
8599 6883
電子郵件
kefengl
mpu.edu
mo
h-index
3197
引文
29
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2025
每年研究成果
概覽
指紋
網路
研究成果
(128)
新聞/媒體
(107)
類似的個人檔案
(6)
指紋
查看啟用 KEFENG LI 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Metabolomics
100%
Metabolite
48%
Blood Plasma
37%
Metabolic Pathway
31%
Dried Blood Spot
17%
Tamsulosin
17%
Genetics
12%
Tandem Mass Spectrometry
11%
Enzyme
11%
Glutamic Acid
11%
Ceramide
11%
Immunity
10%
Wild Type
10%
Prospective Cohort Study
9%
Metabolic Network
8%
Endoplasmic Reticulum Stress
8%
Capillary Electrophoresis Mass Spectrometry
8%
Apparent Diffusion Coefficient
8%
Mendelian Randomization
8%
AKT1
8%
Dysplasia
8%
Single Drug Dose
8%
Capillary Electrophoresis
8%
Suramin
8%
Lipid Metabolism
8%
Salvia Miltiorrhiza
8%
Isocitrate Dehydrogenase
8%
Iron-Deficiency Anemia
8%
Mitochondrial DNA
8%
Tissue Culture
8%
Proteomics
8%
Astaxanthin
8%
Pseudomonas
8%
Metabolic Disorder
8%
Genotyping
8%
Sucrose
8%
Aspartic Acid
8%
Puerarin
8%
Reverse Transcription Polymerase Chain Reaction
8%
Cell Adhesion Proteins
8%
Ginseng
8%
RNA-binding Protein
8%
Bibliometrics
8%
Liquid Chromatography-Mass Spectrometry
7%
Purine Metabolism
7%
Upregulation
6%
Tumor Necrosis Factor
6%
Cancer Cell
5%
Endopeptidase Clp
5%
Cytotoxicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
38%
Biological Marker
28%
Vetiveria
26%
Antidepressant
23%
Phospholipid
19%
Capillary Electrophoresis
17%
Adenosine Triphosphate
17%
Knockout Mouse
17%
Mouse Model
17%
Autism
17%
Receptor
15%
Drug Discovery
15%
Drug Development
14%
Acylcarnitine
11%
Comorbidity
11%
Anti-Inflammatory Drug
10%
Abiotic Stress
9%
Prospective Cohort Study
9%
Amino Acid
9%
Inflammation
9%
Bungarotoxin Receptor
8%
Matrix Metalloproteinase Inhibitor
8%
Community Acquired Pneumonia
8%
Respiratory Tract Disease
8%
Seasonal Influenza
8%
Salvia Miltiorrhiza
8%
Materia Medica
8%
Albiflorin
8%
Disease Model
8%
Callus
8%
Tetrandrine
8%
Plasmalogen
8%
Maize
8%
Nicotinic Receptor
8%
Influenzavirus A
8%
Sepsis
8%
Hypothyroidism
8%
Tanshinone IIA
8%
Enzyme Inhibitor
8%
Drug Metabolism
8%
Glycyrrhiza Uralensis
8%
Liquorice
8%
Antivirus Agent
8%
Ciprofloxacin
8%
2,5-Dimethoxy-4-iodoamphetamine
8%
Iron Deficiency Anemia
8%
Ginseng
8%
Infection
8%
Retrospective Study
8%
Sphingolipid
8%
Medicine and Dentistry
Metabolomics
35%
Metabolite
20%
Biological Marker
17%
Retrospective Study
17%
Ganglioglioma
17%
Systolic Function
17%
Hypochromic Anemia
17%
Personalized Medicine
11%
Clinical Feature
10%
Diseases
10%
Antidepressant
10%
Prospective Cohort Study
9%
Coronary Artery
9%
Magnetic Resonance Imaging
9%
Endoglin
8%
Neointima
8%
Hypothyroidism
8%
Radioiodine Therapy
8%
Graves' Disease
8%
Sepsis
8%
Lung Cancer
8%
Myocardial Bridge
8%
Depression
8%
Cancer Diagnosis
8%
Meta-Analysis
8%
Liver Cirrhosis
8%
Computed Tomography Angiography
8%
Salvia Miltiorrhiza
8%
Chronic Fatigue Syndrome
8%
Lipid Metabolism
8%
Scintigraphy
8%
Hemodynamic
8%
Multidetector Computed Tomography
8%
Precancerous Condition
8%
Isocitrate Dehydrogenase
8%
Immunity
8%
High Fat Food
8%
Adventitious Root
8%
Angina pectoris
8%
Percutaneous Coronary Intervention
8%
Human Milk
8%
Malignant Neoplasm
8%
Anti-Inflammatory Drug
8%
Hydroxylapatite
8%
Roseolic Acid
8%
Sinus Floor Augmentation
8%
Nutrition
8%
In Vitro
8%
Abdominal Cancer
8%
Disease Model
8%
